Latest News
Percheron Capital (Percheron), a private equity firm focused on essential services, has closed its third fund, Percheron Capital Fund III (Fund III), with approximately $3.1bn in total commitments.
Netley Capital, a London-based private investment firm focused on tertiary investing, has secured additional committed capital for its tertiaries franchise, bringing total deployable capital to approximately $825m from $315m at launch in September 2025.
General Atlantic has closed its acquisition of Team Services Holding Inc from Alpine Investors for approximately $3bn, including debt, according to a report by Bloomberg citing unnamed sources familiar with the transaction.
A potential de-escalation of geopolitical tensions in the Middle East may help revive private equity dealmaking momentum in 2026, according to a report by Bloomberg citing comments by Joe Baratta, global head of private equity at Blackstone Inc.
Wealthy investors attempted to withdraw more than $20bn from private credit funds in the first quarter of 2026, highlighting growing pressures on an asset class that has become a major source of capital for leveraged buyouts and PE-backed companies, according to a report by the Financial Times.
Ares Management Corp has named E G Morse as partner and head of Asia credit, as the firm continues to build out its regional leadership across private credit strategies. Based in Hong Kong, Morse succeeds Edwin Wong (pictured), who is set to retire at the end of June.
TPG Inc has engaged Malayan Banking Bhd and UBS Group AG to assess strategic options for Asia OneHealthcare, including a potential sale or public listing, according to a report by Bloomberg citing unnamed sources familiar with the matter.
Italy’s top-tier football league, Serie A, is engaging with private equity investors over a potential minority sale in its international media rights arm, according to a report by Reuters citing unnamed sources familiar with the situation.
Growth-focused healthcare and life sciences private investment firm Petrichor has named Paul J Sekhri as Operating Partner, bolstering its team with an executive who brings more than 35 years of experience across biotech and pharmaceutical sectors.
Jeito Capital, an independent European private equity firm specialising in biopharma investments, has closed its second fund, Jeito II, at a record €1bn ($1.2bn billion), tripling the firm’s assets under management to €1.6bn.
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
